切换至 "中华医学电子期刊资源库"

中华老年骨科与康复电子杂志 ›› 2023, Vol. 09 ›› Issue (05) : 295 -300. doi: 10.3877/cma.j.issn.2096-0263.2023.05.007

骨质疏松

血清IL-2、IL-17和骨密度关系及其对骨质疏松症的预测价值
王娟, 高俊, 周伊兰, 李小红, 史兵伟, 潘美珍()   
  1. 213003 南京中医药大学常州附属医院检验科
    213003 南京中医药大学常州附属医院中医正骨科
  • 收稿日期:2023-05-18 出版日期:2023-10-05
  • 通信作者: 潘美珍
  • 基金资助:
    常州市科技局科技计划(应用基础项目)(CJ20210162); 江苏省科技计划项目(社会发展)(BE2019653)

Relationship between serum IL-2, IL-17 and bone mineral density and their predictive value for osteoporosis

Juan Wang, Jun Gao, Yilan Zhou, Xiaohong Li, Bingwei Shi, Meizhen Pan()   

  1. Department of Laboratory Medicine, Changzhou Hospital of Traditional Chinese Medicine, Changzhou 213003, China
    Department of Chinese Traditional Orthopedics, Changzhou Hospital of Traditional Chinese Medicine, Changzhou 213003, China
  • Received:2023-05-18 Published:2023-10-05
  • Corresponding author: Meizhen Pan
引用本文:

王娟, 高俊, 周伊兰, 李小红, 史兵伟, 潘美珍. 血清IL-2、IL-17和骨密度关系及其对骨质疏松症的预测价值[J/OL]. 中华老年骨科与康复电子杂志, 2023, 09(05): 295-300.

Juan Wang, Jun Gao, Yilan Zhou, Xiaohong Li, Bingwei Shi, Meizhen Pan. Relationship between serum IL-2, IL-17 and bone mineral density and their predictive value for osteoporosis[J/OL]. Chinese Journal of Geriatric Orthopaedics and Rehabilitation(Electronic Edition), 2023, 09(05): 295-300.

目的

检测骨质疏松症患者体内淋巴细胞亚群相应细胞因子的表达并进一步探讨其与疾病的相关性,探讨白介素-2(IL-2)和白介素-17(IL-17)对于骨质疏松疾病诊断的预测价值。

方法

收集40例骨质疏松症[男13例,女27例,年龄(75.58±1.90)岁]和35例[男10例,女25例,年龄(71.67±1.99)岁]年龄相仿的健康人血清样本,使用流式细胞术、化学发光法分别检测其淋巴细胞亚群相应细胞因子水平、Ⅰ型胶原羧基端前肽(PINP)及β-胶原降解产物(β-CTX)水平;使用双能X线骨密度仪检测受试者骨密度;使用受试者工作曲线评价IL-17和IL-2的预测效能。

结果

较健康对照组[(386.9±39.81)pg/ml]相比,骨质疏松症患者体内β-CTX表达上调[(563.7±57.25)pg/ml],差异具有统计学意义(P<0.05);PINP表达具有上调趋势,差异无统计学意义;此外IL-2、IL-10、IL-17呈现明显高表达(P<0.05);进一步分析发现IL-2和IL-17的表达与骨密度具有明显的相关性(r=-0.272,r=-0.380,P<0.05),ROC曲线进一步计算出IL-17和IL-2曲线下面积分别为0.874和0.625。

结论

骨质疏松患者IL-17和IL-2表达水平明显上调,且IL-17可作为骨质疏松症诊断的预测指标。

Objective

To detect the expression of cytokines corresponding to lymphocyte subpopulations in patients with osteoporosis and further investigate their correlation with osteoporosis, and to explore the predictive value of interleukin-17 (IL-17) and interleukin-2 (IL-2) of osteoporosis.

Methods

Serum samples were collected from 40 cases (13 males and 27 females, 75.58±1.90 years) of osteoporosis and 35 healthy subjects (10 males and 25 females, 71.67±1.99 years) of similar age, and their lymphocyte subpopulation corresponding cytokine levels, type I collagen carboxy-terminal prepeptide (PINP) and β-collagen degradation product (β-CTX) levels were measured using flow cytometry and chemiluminescence, respectively; BMD of the patients was measured using dual-energy X-ray bone densitometry; the working curves of the subjects were used to evaluate the predictive efficacy of IL 17 and IL-2 predictive efficacy by subject work curves.

Results

Compared to healthy controls (386.9±39.81 pg/ml), β-CTX expression was up-regulated in osteoporosis patients (563.7±57.25 pg/ml) with statistically significant differences (P<0.05), and PINP expression had a tendency to be up-regulated without statistically significant differences; in addition, IL-2, IL-10 and IL-17 showed significantly high expression (P<0.05), while only the expression of IL-2 and IL-17 correlated with BMD (r=-0.272, r=-0.380, P<0.05); further the ROC curve calculated that the area under the curve of IL-17 and IL-2 were 0.874 and 0.625, respectively.

Conclusions

IL-17 and IL-2 expression levels were significantly up-regulated in osteoporotic patients, and IL-17 can be used as a predictor for the diagnosis of osteoporosis.

图6~8 骨质疏松患者和健康对照组体内IL-2、IL-10、IL-17表达水平。图6 在OP组和CTRL组中IL-2的表达差异;图7 在OP组和CTRL组中IL-10的表达差异;图8 在OP组和CTRL组中IL-17的表达差异
表1 两组患者基线数据比较
图15~16 IL-2和IL-17在骨质疏松中的诊断价值。图15 IL-2对骨质疏松诊断评价ROC曲线;图16 IL-17对骨质疏松诊断评价ROC曲线
1
中国老龄事业发展报告(2022年).中国老龄科学研究中心编写.北京:社会科学文献出版社, 2023: 001-004.
2
《中国老年骨质疏松症诊疗指南》(2018)工作组,中国老年学和老年医学学会骨质疏松分会,马远征,等.中国老年骨质疏松症诊疗指南(2018) [J].中国骨质疏松杂志, 2018, 24(12): 1541-1567.
3
Liu GF, Wang ZQ, Liu L, et al. A network meta-analysis on the short-term efficacy and adverse events of different anti-osteoporosis drugs for the treatment of postmenopausal osteoporosis [J]. J Cell Biochem, 2018, 119(6): 4469-4481.
4
雷礼辉,李峰,罗光平,等.椎体CT值对原发性骨质疏松症唑来膦酸钠疗效的评价价值[J].中华老年骨科与康复电子杂志, 2022 (05): 285-289.
5
许航,崔宇韬,任广凯,等.骨质疏松症关键基因的筛选及生物信息学分析[J].中华老年骨科与康复电子杂志, 2023, 9(1): 18-22.
6
Seifert HA, Benedek G, Nguyen H, et al. Estrogen protects both sexes against EAE by promoting common regulatory cell subtypes Independent of endogenous estrogen [J]. Metab Brain Dis, 2017, 32(5): 1747-1754.
7
Boyce BF, Xing LP. Bruton and Tec: new links in osteoimmunology [J]. Cell Metab, 2008, 7(4): 283-285.
8
Faienza MF, Ventura A, Marzano F, et al. Postmenopausal osteoporosis: the role of immune system cells [J]. Clin Dev Immunol, 2013, 2013: 575936.
9
Clézardin P, Coleman R, Puppo M, et al. Bone metastasis: mechanisms, therapies, and biomarkers [J]. Physiol Rev, 2021, 101(3): 797-855.
10
Horton JE, Raisz LG, Simmons HA, et al. Bone resorbing activity in supernatant fluid from cultured human peripheral blood leukocytes [J]. Science, 1972, 177(4051): 793-795.
11
Wada T, Nakashima T, Hiroshi N, et al. RANKL-RANK signaling in osteoclasto-genesis and bone disease [J]. Trends Mol Med, 2006, 12:17-25.
12
He D, Kou X, Luo Q, et al. Enhanced M1/M2 macrophage ratio promotes orthodontic root resorption [J]. J Dent Res, 2015, 94(1): 129-139.
13
Sun Y, Li JB, Xie XP, et al. Macrophage-Osteoclast associations: origin, polarization, and subgroups [J]. Front Immunol, 2021, 12: 778078.
14
Yao ZQ, Getting SJ, Locke IC. Regulation of TNF-Induced osteoclast differentiation [J]. Cells, 2021, 11(1): 132.
15
Gao YG, Patil S, Jia JX. The development of molecular biology of osteoporosis [J]. Int J Mol Sci, 2021, 22(15): 8182.
16
He D, Kou X, Yang R, et al. M1-like Macrophage Polarization Promotes Orthodontic Tooth Movement [J]. J Dent Res, 2015, 94(9): 1286-1294.
17
He DQ, Liu FL, Cui SJ, et al. Mechanical load-induced H2S production by periodontal ligament stem cells activates M1 macrophages to promote bone remodeling and tooth movement via STAT1 [J]. Stem Cell Res Ther, 2020, 11(1): 112.
18
Li CH, Palanisamy K, Li X, et al. Exosomal tumor necrosis factor-α from hepatocellular cancer cells (Huh-7) promote osteoclast differentiation [J]. J Cell Biochem, 2021, 122(11): 1749-1760.
19
Hukkanen M, Hughes FJ, Buttery LD, et al. Cytokine-stimulated expression of inducible nitric oxide synthase by mouse, rat, and human osteoblast-like cells and its functional role in osteoblast metabolic activity [J]. Endocrinology, 1995, 136(12): 5445-5453.
20
Stock JL, Coderre JA, DeVito WJ, et al. Effects of human lymphocyte-conditioned medium on MG-63 human osteosarcoma cell function [J]. Cytokine, 1998, 10(8): 603-612.
21
Lubberts E, Joosten LA, Chabaud M, et al. IL-4 gene therapy for collagen arthritis suppresses synovial IL-17 and osteoprotegerin ligand and prevents bone erosion [J]. J Clin Invest, 2000, 105(12): 1697-1710.
22
Min HK, Kim S, Lee JY, et al. IL-18 binding protein suppresses IL-17-induced osteoclastogenesis and rectifies type 17 helper T cell/regulatory T cell imbalance in rheumatoid arthritis [J]. J Transl Med, 2021, 19(1): 392.
23
Yan Y, Liu F, Kou X, et al. T cells are required for orthodontic tooth movement [J]. J Dent Res, 2015, 94(10): 1463-1470.
24
Takayanagi H, Ogasawara K, Hida S, et al. T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-gamma [J]. Nature, 2000, 408(6812): 600-605.
25
Gao YH, Grassi F, Ryan MR, et al. IFN-gamma stimulates osteoclast formation and bone loss in vivo via antigen-driven T cell activation [J]. J Clin Invest, 2007, 117(1): 122-132.
26
Ayon Haro ER, Ukai T, Yokoyama M, et al. Locally administered interferon-γ accelerates lipopolysaccharide-induced osteoclastogenesis Independent of immunohistological RANKL upregulation [J]. J Periodontal Res, 2011, 46(3): 361-373.
27
Klatzmann D, Abbas AK. The promise of low-dose interleukin-2 therapy for autoimmune and inflammatory diseases [J]. Nat Rev Immunol, 2015, 15(5): 283-294.
28
Wiwanitkit V. Effect of interleukin-2 and tumor necrosis factor-alpha on osteopontin: molecular function and biological process [J]. Pediatr Int, 2008, 50, 213-215.
29
Schneider GB, Relfson M. Effects of interleukin-2 on bone resorption and natural immunity in osteopetrotic (ia) rats [J]. Lymphokine Cytokine Res, 1994, 13(6): 335-341.
30
Miossec P, Korn T, Kuchroo VK. Interleukin-17 and type 17 helper T cells [J]. N Engl J Med, 2009, 361(9): 888-898.
31
Martinez GJ, Nurieva RI, Yang XO, et al. Regulation and function of proinflammatory TH17 cells [J]. Ann N Y Acad Sci, 2008, 1143: 188-211.
32
Komatsu N, Takayanagi H. Autoimmune arthritis: the interface between the immune system and joints [J]. Adv Immunol, 2012, 115: 45-71.
33
Waisman A. T helper cell populations: as flexible as the skin? [J]. Eur J Immunol, 2011, 41(9): 2539-2543.
34
Tyagi AM, Srivastava K, Mansoori MN, et al. Estrogen deficiency induces the differentiation of IL-17 secreting Th17 cells: a new candidate in the pathogenesis of osteoporosis [J]. PLoS One, 2012, 7(9): e44552.
35
Oishi Y, Watanabe Y, Shinoda S, et al. The IL6 gene polymorphism - 634C>G and IL17F gene polymorphism 7488T>C influence bone mineral density in young and elderly Japanese women [J]. Gene, 2012, 504(1): 75-83.
36
Wang Z, Wei Y, Lei L, et al. RANKL expression of primary osteoblasts is enhanced by an IL-17-mediated JAK2/STAT3 pathway through autophagy suppression [J]. Connect Tissue Res, 2021, 62(4): 411-426.
[1] 蒲彦婷, 吴翠先, 兰玉梅. 类风湿关节炎患者骨质疏松症风险预测列线图模型构建[J/OL]. 中华关节外科杂志(电子版), 2024, 18(05): 596-603.
[2] 郑永乐, 庞祖才, 陈家敏, 孙丙银. 骨碎补总黄酮抑制牵张成骨模型骨质疏松的作用研究[J/OL]. 中华关节外科杂志(电子版), 2024, 18(05): 604-608.
[3] 蚁淳, 袁冬生, 熊学军. 系统免疫炎症指数与骨密度降低和骨质疏松的关联[J/OL]. 中华关节外科杂志(电子版), 2024, 18(05): 609-617.
[4] 戴睿, 张亮, 陈浏阳, 张永博, 吴丕根, 孙华, 杨盛, 孟博. 肠道菌群与椎间盘退行性变相关性的研究进展[J/OL]. 中华损伤与修复杂志(电子版), 2024, 19(06): 546-549.
[5] 赖全友, 高远, 汪建林, 屈士斌, 魏丹, 彭伟. 三维重建技术结合腹腔镜精准肝切除术对肝癌患者术后CD4+、CD8+及免疫球蛋白水平的影响[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 651-654.
[6] 赵月, 田坤, 张宗明, 郭震天, 刘立民, 张翀, 刘卓. 降钙素原对老年急性重度胆囊炎发生的预测价值[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 801-806.
[7] 刘敏思, 李荣, 李媚. 基于GGT与Plt比值的模型在HBV相关肝细胞癌诊断中的作用[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 831-835.
[8] 伍细蓉, 徐立文, 陈亚琼. 基于LPR和FARI构建肝衰竭患者生存预后模型[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(05): 675-681.
[9] 施麟宵, 洪兰兰, 阳柳, 芶碧珍, 刘畅, 吴欣. 钠-葡萄糖协同转运蛋白2 抑制剂治疗原发性膜性肾病的疗效及其对Th1/Th2 的影响[J/OL]. 中华肾病研究电子杂志, 2024, 13(05): 261-267.
[10] 黄韬, 杨晓华, 薛天森, 肖睿. 改良“蛋壳”技术治疗老年OVCF及对脊柱矢状面平衡参数、预后的影响[J/OL]. 中华老年骨科与康复电子杂志, 2024, 10(06): 340-348.
[11] 谭明明, 战世强, 侯宏涛, 曾翔硕. 经皮微创椎弓根螺钉内固定术对骨质疏松脊柱压缩性骨折患者临床研究[J/OL]. 中华老年骨科与康复电子杂志, 2024, 10(06): 349-354.
[12] 王芳, 刘达, 左智炜, 盛金平, 陈庭进, 蒋锐. 定量CT与双能X线骨密度仪对骨质疏松诊断效能比较的Meta分析[J/OL]. 中华老年骨科与康复电子杂志, 2024, 10(06): 363-371.
[13] 周锐, 罗飞. 骨质疏松椎体骨折的分型进展[J/OL]. 中华老年骨科与康复电子杂志, 2024, 10(05): 315-320.
[14] 崔健, 夏青, 林云, 李光玲, 李心娜, 王位. 血小板与淋巴细胞比值、免疫球蛋白、心肌酶谱及心电图对中老年肝硬化患者病情及预后的影响[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(05): 400-406.
[15] 马豆豆, 丁艳, 古今, 王丽芳, 石连杰. 以发热为首发表现的强直性脊柱炎合并潜伏性结核感染一例[J/OL]. 中华临床医师杂志(电子版), 2024, 18(08): 791-794.
阅读次数
全文


摘要